MDT
96.14
-0.57%↓
A
136.19
-1%↓
VEEV
223.11
-0.69%↓
HQY
91.51
-0.5%↓
PHR.US
16.9
-0.59%↓
MDT
96.14
-0.57%↓
A
136.19
-1%↓
VEEV
223.11
-0.69%↓
HQY
91.51
-0.5%↓
PHR.US
16.9
-0.59%↓
MDT
96.14
-0.57%↓
A
136.19
-1%↓
VEEV
223.11
-0.69%↓
HQY
91.51
-0.5%↓
PHR.US
16.9
-0.59%↓
MDT
96.14
-0.57%↓
A
136.19
-1%↓
VEEV
223.11
-0.69%↓
HQY
91.51
-0.5%↓
PHR.US
16.9
-0.59%↓
MDT
96.14
-0.57%↓
A
136.19
-1%↓
VEEV
223.11
-0.69%↓
HQY
91.51
-0.5%↓
PHR.US
16.9
-0.59%↓
24h
Current
Min
30.68
Max
31.34
Income | 66M -35M |
|---|---|
Sales | 70M 71M |
Profit margin | -49.028 |
Employees | 143 |
EBITDA | 66M -34M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +32.27% upside |
Market Cap | 855M 3B |
|---|---|
Previous open | 30.08 |
Previous close | 31.09 |
By Acuity
50%
50%
157 / 374 Ranking in Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
12 / 13.14 Support & Resistance
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
31 gru 2025, 22:20 UTC
Outlook Therapeutics Shares Fall After Another FDA Rejection of Macular Degeneration Drug
DJ
Read
31 gru 2025, 17:31 UTC
OwlTing Climbs on Launch of $10 Million Stock-Buyback Program
DJ
Read
31 gru 2025, 16:30 UTC
Trump Media Gains on Plan to Distribute Digital Tokens to Shareholders
DJ
Read
31 gru 2025, 15:19 UTC
Axsome Shares Climb on FDA Fast‑Track for Alzheimer's Drug, Backing for Narcolepsy Filing
DJ
Read
31 gru 2025, 15:17 UTC
Nike Shares Rise After CEO Hill Buys $1 Million of Shares
DJ
Read
31 gru 2025, 14:37 UTC
Corcept Shares Fall as FDA Requires More Evidence for Hypercortisolism Drug Application
DJ
Read
31 gru 2025, 21:50 UTC
Basic Materials Roundup: Market Talk
DJ
Read
31 gru 2025, 21:13 UTC
10 People to Watch in Wealth Management in 2026 -- Barrons.com
DJ
Read
31 gru 2025, 20:40 UTC
Dollar Posting Its Worst Year Since 2017 -- Market Talk
DJ
Read
31 gru 2025, 20:22 UTC
Oil Posts Loss in a Year Marked By Plentiful Supply -- Market Talk
DJ
Read
31 gru 2025, 19:50 UTC
U.S. Natural Gas Futures Sink on Weather Outlook -- Market Talk
DJ
Read
31 gru 2025, 19:31 UTC
Precious Metals Cap Off Record Runs -- Market Talk
DJ
Read
31 gru 2025, 18:50 UTC
Global Equities Roundup: Market Talk
DJ
Read
31 gru 2025, 18:50 UTC
Canadian Gold Miners Enjoy a Bumper Year in 2025 -- Market Talk
DJ
Read
31 gru 2025, 17:17 UTC
U.S. Natural Gas Inventories Fall Less Than Expected -- Market Talk
DJ
Read
31 gru 2025, 17:16 UTC
OwlTing Climbs on Launch of $10M Stock-Buyback Program
DJ
Read
31 gru 2025, 17:15 UTC
Global Commodities Roundup: Market Talk
DJ
Read
31 gru 2025, 17:00 UTC
Nvidia Is Getting Creative as Options to Use Its Cash Flood Narrow -- Heard on the Street -- WSJ
DJ
Read
31 gru 2025, 15:57 UTC
Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval -- Barrons.com
DJ
Read
31 gru 2025, 15:54 UTC
Layoff Data Supports Dollar at End of Losing Year -- Market Talk
DJ
Read
31 gru 2025, 15:02 UTC
Nike Shares Rise After CEO Hill Buys $1M of Shares
DJ
Read
31 gru 2025, 14:40 UTC
Nike CEO Buys $1 Million of Stock as Insiders Bet on a Turnaround -- Barrons.com
DJ
Read
31 gru 2025, 14:20 UTC
Crude Futures On Track to End the Year With Losses -- Market Talk
DJ
Read
31 gru 2025, 13:46 UTC
U.S. Natural Gas Falls on Milder Weather Outlook -- Market Talk
DJ
Read
31 gru 2025, 13:01 UTC
Charles Schwab Is Back on Offense. Its Stock Is a Buy. -- Barrons.com
DJ
Read
31 gru 2025, 11:10 UTC
Copper Remains in Touching Distance of Record Highs -- Market Talk
DJ
Read
31 gru 2025, 10:46 UTC
Euro on Track For Strong Annual Performance -- Market Talk
DJ
Read
31 gru 2025, 10:25 UTC
European Gas Prices Rise But Remain on Track for Heavy Annual Loss -- Market Talk
DJ
Read
31 gru 2025, 10:23 UTC
Chinese Yuan Rises to 31-Month High Against Dollar as Policymakers -- Market Talk
DJ
Read
31 gru 2025, 09:33 UTC
Dollar Set For Worst Annual Performance Since 2017 -- Market Talk
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 41.03 USD 32.27%
High 61 USD
Low 14.382 USD
Based on 16 Wall Street analysts offering 12 month price targets forVIRIDIAN THERAPEUTICS INC - Dist in the last 3 months.
By TipRanks
Strong Buy
16 ratings
16
Buy
0
Hold
0
Sell
Based on 16 analysts giving stock ratings to VIRIDIAN THERAPEUTICS INC - Dist in the past 3 months.
By Trading Central
Short Term
Very Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Intermediate Term
Bearish Evidence
All events are bearish.
Long Term
Strong Bearish Evidence
All events are bearish.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$